Back to top
more

Danaher (DHR)

(Real Time Quote from BATS)

$269.50 USD

269.50
36,101

+0.69 (0.26%)

Updated Oct 9, 2024 09:54 AM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy23.68%
2Buy17.55%
3Hold9.21%
4Sell4.93%
5Strong Sell2.36%
S&P50010.96%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

3-Hold of 5     3    

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

F Value F Growth D Momentum F VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Top 42% (105 out of 252)

Industry: Diversified Operations

Zacks Premium FeatureView All Zacks #1 Ranked Stocks

Better trading starts here.

Zacks News

Danaher (DHR) Earnings Expected to Grow: What to Know Ahead of Next Week's Release

by Zacks Equity Research

Danaher (DHR) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Mark Vickery headshot

Top Analyst Reports for Mastercard, Honeywell & Thermo Fisher

by Mark Vickery

Today's Research Daily features new research reports on 16 major stocks, including Mastercard (MA), Honeywell (HON) and Thermo Fisher (TMO).

UTX or DHR: Which Is the Better Value Stock Right Now?

by Zacks Equity Research

UTX vs. DHR: Which Stock Is the Better Value Option?

UTX vs. DHR: Which Stock Should Value Investors Buy Now?

by Zacks Equity Research

UTX vs. DHR: Which Stock Is the Better Value Option?

Danaher to Gain From Solid Demand in Key Markets Amid Risks

by Zacks Equity Research

Effective implementation of Danaher Business System and solid demand for innovative products are likely to boost Danaher's (DHR) revenues.

Danaher's Stock Offering Proceeds to Fund BioPharma Buyout

by Zacks Equity Research

Danaher (DHR) successfully completes the offering of common and preferred shares. It intends on using the funds raised to pay for the pending acquisition of General Electric's BioPharma business.

GE Intends to Lower Debt Burden, Boost Dividend Payments

by Zacks Equity Research

General Electric (GE) seeks to become more competent on the back of its initiatives to improve financial position and strengthen core businesses.

Danaher to Buy BioPharma, Offers Common & Preferred Shares

by Zacks Equity Research

Danaher (DHR) to gain from the buyout of the BioPharma business. This is likely to strengthen its biologics workflow solutions business. The company offers common and preferred shares.

General Electric (GE) to Divest BioPharma, Closes Wabtec Deal

by Zacks Equity Research

General Electric (GE) to gain from divestiture of the BioPharma business by using the proceeds to lower debt burden and focus on more important portfolios. It completes GE Transportation divestment.

Company News For Feb 26, 2019

by Zacks Equity Research

Companies In The News Are: DHR,GE,ONCE,CMTA,CRI

Danaher (DHR) Catches Eye: Stock Jumps 8.5%

by Zacks Equity Research

Danaher (DHR) saw a big move last session, as its shares jumped nearly 9% on the day, amid huge volumes.

Mark Vickery headshot

Pre-Markets Up, GE Sells Off Biopharma Biz

by Mark Vickery

With President Trump again delaying the 25% tariff rate and GE raising over $21 billion to pay down debt, futures are in the green this morning.

Positive Development on Trade War Front

by Zacks Equity Research

Positive Development on Trade War Front

Mark Vickery headshot

Pre-Markets Up, GE Sells Off Biopharma Biz

by Mark Vickery

With President Trump again delaying the 25% tariff rate and GE raising over $21 billion to pay down debt, futures are in the green this morning.

The Zacks Analyst Blog Highlights: ExxonMobil, Merck, Danaher, Novartis and Expedia

by Zacks Equity Research

The Zacks Analyst Blog Highlights: ExxonMobil, Merck, Danaher, Novartis and Expedia

Mark Vickery headshot

Top Research Reports for ExxonMobil, Merck & Danaher

by Mark Vickery

Today's Research Daily features new research reports on 16 major stocks, including ExxonMobil (XOM), Merck (MRK) and Danaher (DHR).

CSL or DHR: Which Is the Better Value Stock Right Now?

by Zacks Equity Research

CSL vs. DHR: Which Stock Is the Better Value Option?

Danaher (DHR) Q4 Earnings & Revenues Beat Estimates, Up Y/Y

by Zacks Equity Research

Danaher's (DHR) Q4 earnings jump year over year on the back of solid performance across all its segments.

Danaher (DHR) Q4 Earnings and Revenues Beat Estimates

by Zacks Equity Research

Danaher (DHR) delivered earnings and revenue surprises of 0.79% and 0.80%, respectively, for the quarter ended December 2018. Do the numbers hold clues to what lies ahead for the stock?

MMM, DHR Q4 Earnings on Jan 29: Here are the Key Predictions

by Zacks Equity Research

Conglomerates sector's earnings are expected to decline year over year in Q4. Read to know how 3M Company (MMM) and Danaher (DHR) are likely to fare.

Can Danaher (DHR) Maintain its Beat Streak in Q4 Earnings?

by Zacks Equity Research

Strength in Life Sciences business, accretive acquisitions and a solid product portfolio are conducive to Danaher's (DHR) likely encouraging Q4 results. However, high cost of sales remains a drag.

CSL or DHR: Which Is the Better Value Stock Right Now?

by Zacks Equity Research

CSL vs. DHR: Which Stock Is the Better Value Option?

ITT or DHR: Which Is the Better Value Stock Right Now?

by Zacks Equity Research

ITT vs. DHR: Which Stock Is the Better Value Option?

ITT vs. DHR: Which Stock Is the Better Value Option?

by Zacks Equity Research

ITT vs. DHR: Which Stock Is the Better Value Option?

Danaher (DHR) Displays Bright Prospects, Headwinds Remain

by Zacks Equity Research

Sturdier demand for innovative products, along with effective implementation of Danaher Business System to boost Danaher's (DHR) revenues despite certain headwinds.